Cargando…
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
BACKGROUND: Human mutations in the X‐linked lysosome‐associated membrane protein‐2 (LAMP2) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an in‐frame LA...
Autores principales: | Alcalai, Ronny, Arad, Michael, Wakimoto, Hiroko, Yadin, Dor, Gorham, Joshua, Wang, Libin, Burns, Elia, Maron, Barry J., Roberts, William C., Konno, Tetsuo, Conner, David A., Perez‐Atayde, Antonio R., Seidman, Jon G., Seidman, Christine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649277/ https://www.ncbi.nlm.nih.gov/pubmed/34459252 http://dx.doi.org/10.1161/JAHA.120.018829 |
Ejemplares similares
-
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
por: Onoue, Kenji, et al.
Publicado: (2021) -
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
por: Reichart, Daniel, et al.
Publicado: (2023) -
Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere
por: Agarwal, Radhika, et al.
Publicado: (2022) -
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model
por: Axelsson Raja, Anna, et al.
Publicado: (2022) -
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)